Both in Pharmaceuticals
Ligand Pharmaceuticals vs Ionis Pharmaceuticals
Over the past year LGND returned +64.4% and IONS returned −45.4%; their daily moves had a correlation of 0.19.
LGND +64.4% IONS −45.4%Growth of $1, one year, split-adjusted
| Metric | LGND | IONS |
|---|---|---|
| Price | $314.41 | $40.18 |
| Market cap | $6.29B | $6.68B |
| Today | +0.28% | −0.59% |
| 1 month | +5.9% | −8.7% |
| 6 months | +35.2% | −47.7% |
| Year to date | +66.3% | −49.2% |
| 1 year | +64.4% | −45.4% |
| Revenue growth (YoY) | −31.8% | −40.7% |
| Gross margin | 83.7% | 99.0% |
| Net margin | −36.2% | −42.8% |
| P/E (TTM) | 122.2× | — |
| Price / sales | 24.8× | 7.6× |
| Net cash | -$653.3M | $732.0M |
| Dividend yield | — | — |
| Volatility (60d) | 29.3% | 43.5% |
| Short % of float | 13.3% | 12.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).